Discovery of Potent, Nonsystemic Apical Sodium-Codependent Bile Acid Transporter Inhibitors (Part 2)-Reference-Cited by-同舟云学术

Discovery of Potent, Nonsystemic Apical Sodium-Codependent Bile Acid Transporter Inhibitors (Part 2)

Published:2005-08-06 Issue:18 Volume:48 Page:5853-5868
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Huang Horng-Chih¹,Tremont Samuel J.¹,Lee Len F.¹,Keller Bradley T.¹,Carpenter Andrew J.¹,Wang Ching-Cheng¹,Banerjee Shyamal C.¹,Both Scott R.¹,Fletcher Theresa¹,Garland Danny J.¹,Huang Wei¹,Jones Claude¹,Koeller Kevin J.¹,Kolodziej Steve A.¹,Li James¹,Manning Robert E.¹,Mahoney Matthew W.¹,Miller Raymond E.¹,Mischke Deborah A.¹,Rath Nigam P.¹,Reinhard Emily J.¹,Tollefson Michael B.¹,Vernier William F.¹,Wagner Grace M.¹,Rapp Steve R.¹,Beaudry Judy¹,Glenn Kevin¹,Regina Karen¹,Schuh Joe R.¹,Smith Mark E.¹,Trivedi Jay S.¹,Reitz David B.¹

Affiliation:

1. Department of Discovery Chemistry and Department of Cardiovascular Disease, Pharmacia, 700 Chesterfield Parkway W, Chesterfield, Missouri 63017, Office of Science and Technology, Chemical Science Division, Pharmacia, 800 Lindbergh Boulevard, Creve Coeur, Missouri 63167, Department of Pharmaceutical Sciences, Pharmacia, Skokie, Illinois, and Department of Chemistry, University of Missouri, St. Louis, Missouri

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0402162

Reference14 articles.

1. Overall mortality in the program on the surgical control of the hyperlipidemias1 1No competing interests declared.

2. The myotoxicity of statins

3. Effects of HMG-CoA Reductase Inhibitors on Skeletal Muscle

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IBAT inhibitors in pediatric cholestatic liver diseases: Transformation on the horizon?;Hepatology;2024-07-25

2. Exploring the interplay of Emotional intelligence and stress;Bulletin of Integrative Psychiatry;2024-06-15

3. The macrocycle inhibitor landscape of SLC‐transporter;Molecular Informatics;2024-03-05

4. Membrane transporters in drug development and as determinants of precision medicine;Nature Reviews Drug Discovery;2024-01-24

5. Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023;Molecules;2023-12-21